Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07300007
PHASE1

PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults

Sponsor: Aspargo Labs, Inc

View on ClinicalTrials.gov

Summary

The study will evaluate the pharmacokinetics and relative bioavailability of two liquid metformin formulations (100 mg/mL and 250 mg/mL)

Official title: An Open-Label, Randomized, Crossover Study to Characterize the Pharmacokinetics and Relative Bioavailability of Liquid Metformin at 100 mg/mL and 250 mg/mL Compared With Standard Metformin Tablets

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-03-15

Completion Date

2026-05-28

Last Updated

2025-12-23

Healthy Volunteers

Yes

Interventions

DRUG

Liquid Metformin 100 mg/mL

A single oral dose of liquid metformin at a concentration of 100 mg/mL will be administered under fasting conditions in one treatment period of the crossover.

DRUG

Liquid Metformin 250 mg/mL

A single oral dose of liquid metformin at a concentration of 250 mg/mL will be administered under fasting conditions in one treatment period of the crossover.